FDA Clearance Tracker · K260337
SEEG-Tx® System (STX-SYS-001)
Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Oct 29, 2026
Substantially Equivalent
Time to decision
269 days
Received Feb 2, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K260337
- Device name
- SEEG-Tx® System (STX-SYS-001)
- Applicant
- Dixi Medical
- Applicant location
- Marchaux-Chaudefontaine, FR
- Received
- Feb 2, 2026
- Decided
- Oct 29, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Generator, Lesion, Radiofrequency (GXD)
- Device class
- Class II
- Regulation
- 21 CFR 882.4400
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GXD. The earliest in FDA's data is K896450, decided Mar 19, 1991.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K260337
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Dixi Medical
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K202087 · Decided Nov 18, 2021 · 478 days after receipt
Device type: Electrode, Depth (GZL) · Neurology & Neurosurgery
K201931 · Decided Oct 2, 2021 · 446 days after receipt
Device type: Electrode, Cortical (GYC) · Neurology & Neurosurgery
K170959 · Decided Nov 24, 2017 · 238 days after receipt
Device type: Electrode, Depth (GZL) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.